MSH Advanced CV Imaging Fellowship

Check out our brand new Advanced CV Imaging Fellowship Website! icahn.mssm.edu/education/resi… @doctorginaL @SWBienMD @DLBHATTMD @lesleejshaw @MountSinaiHeart @SinaiCards @MSHCardsCT @MSH_MedChiefs

What is the success of image acquisition in PC versus EID CT? See the “Success Cube” @Heart_SCCT @MSHCVImaging @DLBHATTMD @lesleejshaw

That’s a wrap! @Heart_SCCT 2026! Wonderful catching up with friends while making new ones! Until next year! @MSHCVImaging @MountSinaiHeart @SinaiCards

Cardiologist Solomon W. Bienstock, MD, recently shared insights on how brisk walking can help lower blood pressure and support heart health. His expertise underscores the value of sustainable lifestyle habits for cardiovascular disease prevention: bit.ly/4b8WJc0

SCCT 2026! The future is now! #PowerofCardiacCT @MSHCVImaging @MountSinaiHeart @SinaiCards

Off to SCCT 2026 in San Diego! Hope to connect with colleagues and friends! @MichaelHadleyMD @acamajmd @MSHCVImaging @MountSinaiHeart

#cardiology #cardiovascular #cardiotwitter #cardioX

Welcome to our new cardiac imaging fellows @MountSinaiHeart @MSHCVImaging! @HarryChoi @DLBHATTMD @lesleejshaw @SinaiCards

How Far and How Fast You Should Walk to Lower Blood Pressure? It was wonderful discussing this topic with Health.com! @MountSinaiHeart @IcahnMountSinai @MountSinaiNYC @SinaiCards @MSHCVImaging @DLBHATTMD health.com/how-far-and-ho…

Congrats to our incredible Cardiac CT team here at @MountSinaiHeart! Special shout out to our wonderful techs and nurses! @DLBHATTMD @lesleejshaw @SWBienMD @Heartflow

End of the academic year! Our amazing fellow, Shreyans Patel is graduating and joining the team here at @MountSinaiHeart. Our very own @SinaiCards @HarryChoiMD and Alexander Levy are starting as our new fellows! @SWBienMD @DLBHATTMD @lesleejshaw

The wait is over! The @SiemensHealth Alpha.Peak is here @MountSinaiHeart. The future is now! @SWBienMD @lesleejshaw @DLBHATTMD

Congratulations to the 2026 SCCT Award winners, who will receive their awards at the Opening Session of #SCCT2026 on Friday, July 10 at the Gaylord Pacific Resort & Convention Center, Chula Vista, Calif. @DrMichaelShapir Join us! ow.ly/LzGY50YRIIB

Dr. Sharma invites YOU to the 2026 CCC Symposium! Join us on June 16-18 at The Mount Sinai Hospital & New York Marriott Marquis - Register NOW! cccsymposium.org #cardiology #interventionalcardiology #coronaryintervention #coronaryarterydisease #mountsinaihospital

#cardiology #cardiovascular #prevention #cardiotwitter #cardioX

We are proud to announce the launch of the Adams Valve Institute, a new global center dedicated to advancing comprehensive care and surgical techniques for patients with heart valve disease. The Adams Valve Institute builds on more than two decades of pioneering work by David H. Adams, MD. This Institute will unite a multidisciplinary team of experts to promote innovation in advanced imaging, reconstructive surgical techniques, peer-to-peer education, health policy reform, and breakthrough research across the full spectrum of valvular heart disease. Ismail El-Hamamsy, MD, PhD, will serve as the inaugural Director of the Adams Valve Institute. Read more about the Institute: mshs.co/4mhAjtr

⚠️Women may not need as much coronary plaque as men to get into trouble. 🫀New @CircAHA analysis quantified total plaque burden (plaque volume/vessel volume) in 4267 patients with CP undergoing #CCTA. Women had less plaque and lower plaque volumes, but risk “turned on” earlier:

Adam Jacobi, head of cardiothoracic radiology, giving a wonderful talk on imaging endocarditis during our biweekly conference @MSHCVImaging @SWBienMD @SinaiCards @MountSinaiHeart

🚨 New study in #EJPC: ✅Life’s Essential 8 is inversely associated with HF risk ✅Individuals with initially low LE8 levels experience a reversal in HF risk upon improvement 💻 ow.ly/EoEF50X01cN @EJPCEiC @AboyansV @EAPCPresident @SilCastelletti @PeroneFrancesco @PTBuketAkinci @justvick

🌟🌟Coronary artery disease: a BIG movement to change from reactive end-stage treatment to early detection and treatment: thelancet.com/action/showPdf… Kudos to the The Lancet Commission for actively studying the global health benefits of this paradigm shift from "ischemic" heart disease to atherosclerosis!🌟🌟

A major advancement in cardiovascular care: A new international study led by Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital, has found that sotagliflozin, an FDA-approved SGLT inhibitor for type 2 diabetes and kidney disease, significantly reduces heart attacks and strokes. Published in The Lancet Diabetes & Endocrinology, the trial is the first to demonstrate these unique benefits from dual SGLT1 and SGLT2 inhibition. The findings could shift how we treat cardiovascular risk in patients with diabetes and chronic kidney disease. Read the Specialty Report here: mshs.co/4muq1oZ